Fig. 9From: Aspartoacylase suppresses prostate cancer progression by blocking LYN activationThe mechanism of ASPA in PCa. ASPA aspartoacylase, AP-1 Activator protein-1, C-Jun v-Jun avian sarcoma virus 17 oncogene homolog, JNK c-Jun N-terminal kinase, LYN Lck/Yes-related novel protein tyrosine kinase, PCa prostate cancerBack to article page